Dollars for Docs - ProPublica

From http://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.

Payment Category

Payment period

With 2 Million records, this database represents:

$2.1 billion

in disclosed payments

15

companies

~ 47%

of total market share

Payments in Your State

Click on a state to see payments made to practitioners and institutions there. See notes below.

Alabama$26,650,785
Alaska$497,019
Arizona$31,322,594
Arkansas$13,093,875
California$245,426,008
Colorado$31,726,642
Connecticut$28,799,062
Delaware$3,806,129
District of Columbia$8,182,279
Florida$172,940,919
Georgia$54,733,386
Hawaii$3,252,737
Idaho$7,522,721
Illinois$69,778,363
Indiana$36,318,156
Iowa$10,547,297
Kansas$25,066,858
Kentucky$26,341,044
Louisiana$23,284,061
Maine$3,763,637
Maryland$46,752,272
Massachusetts$98,217,577
Michigan$49,094,722
Minnesota$26,689,687
Mississippi$9,346,971
Missouri$50,048,268
Montana$2,672,796
Nebraska$15,869,287
Nevada$12,858,667
New Hampshire$5,995,299
New Jersey$57,268,034
New Mexico$7,189,701
New York$144,101,323
North Carolina$73,390,960
North Dakota$5,098,812
Ohio$83,344,844
Oklahoma$20,539,751
Oregon$21,551,614
Pennsylvania$99,168,664
Rhode Island$12,539,542
South Carolina$38,831,666
South Dakota$3,100,279
Tennessee$48,252,057
Texas$163,304,438
Utah$26,170,810
Vermont$1,845,993
Virginia$33,482,489
Washington$36,097,167
West Virginia$6,493,809
Wisconsin$23,546,140
Wyoming$470,491
Puerto Rico$12,438,331
[Unknown State]$611,157

Company Disclosures

The totals listed here cover different time periods and spending categeories, and aren't directly comparable. See notes below. See what each company discloses »

CompanyTotal Disclosed
AbbVieDisclosed: July to Sept. 2012$6.9M
AllerganDisclosed: July 2011 to Sept. 2012Ranges*
AstraZenecaDisclosed: Jan. 2010 to Sept. 2012$236.1M
CephalonDisclosed: Jan. 2009 to Dec. 2012$89.7M
Eli LillyDisclosed: Jan. 2009 to June 2012$490.6M
EMD SeronoDisclosed: Jan. 2011 to Sept. 2012$4M
ForestDisclosed: Jan. to Dec. 2012$95.6M
GlaxoSmithKlineDisclosed: April 2009 to Sept. 2012$238.6M
Johnson & JohnsonDisclosed: Jan. 2010 to Sept. 2012$54.6M
MerckDisclosed: July 2009 to Sept. 2012$224.3M
NovartisDisclosed: Oct. 2010 to Sept. 2012$54.2M
PfizerDisclosed: July 2009 to Sept. 2012$538.2M
UCBDisclosed: Jan. to Sept., 2012$7.2M
ValeantDisclosed: Jan. 10, 2010 to Sept. 2012Ranges*
ViiVDisclosed: Jan. 2010 to Sept. 2012$18.4M

Notes: Disclosures made or altered since Jan. 2013 are not listed or reflected on this website. Because they are reported in ranges, some of Valeant's payments and all of Allergan's payments are excluded from state and national totals. Also, Valeant did not disclose any payments between Sept. 27, 2010 and Jan. 1, 2011.

Local Stories Based on This Data

See recent stories that use our data below. Interested in being notified when we update our app? Find out how.

See more stories +

Our Stories

We've identified 22 doctors who've earned at least $500,000 since 2009.

New data show drugmakers' payments to hundreds of thousands of doctors, and some have made well over $500,000.

Background Stories

Reporters, Use Our Data

Have questions about how you can best use Dollars for Docs for your own localized reporting? Contact Nicole Collins Bronzan at communications@propublica.org.

Additional reporting and development by Jennifer LaFleur, Joe Kokenge, Liz Day, David Frackman, Jeff Larson and Jason Das. Pharmacy icon from The Noun Project.

http://projects.propublica.org/docdollars/